Canada

Search form

Aptima Mycoplasma genitalium assay

Mycoplasma genitalium is an STI that is associated with serious reproductive consequences including PID, infertility and ectopic pregnancy.1 First discovered in the 1980s, M. genitalium infections are present in up to 12% of men and women, a prevalence similar to chlamydia and gonorrhea.2 Symptoms, when present, may be consistent with cervicitis or urethritis.2,3 In response to high infection rates and a lack of sensitive diagnostic methods, Hologic developed the Aptima Mycoplasma genitalium assay, the first CE-marked sample-to-result Mycoplasma genitalium assay on the automated Panther system.

References

References  1. Johansen TB, et al. The ‘Finnish new variant of Chlamydia trachomatis’ escaping detection in the Aptima Combo 2 assay is widespread across Norway, June to August 2019. Euro Surveill. 2019;24(42):pii=1900592. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.42.... 2. CDC. Sexually Transmitted Diseases and Treatment Guidelines: Mycoplasma genitalium. http://www.cdc.gov/std/tg2015/emerging.htm. Updated June 4, 2015. Accessed January 8, 2019.3. Aptima Mycoplasma genitalium assay [package insert]. AW-17946 Rev.002 San Diego, CA: Hologic, Inc.; 2019.